Industry Regulation White Paper
21 CFR Part 606, also known as Current Good Manufacturing Practice for Blood and Blood Components, outlines requirements for blood labeling, laboratories, reporting, and recordkeeping. It is meant to ensure that blood and blood components for human use are safe, pure, and effective.
This white paper provides a concise look at how SmartSolve can help your organization comply with the various sub-parts of 21 CFR Part 606.
Download this white paper to learn more. »